US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Temasek Holdings

1,254.50

+27.052.20%

Number of Gainers:77

Number of Losers:7

Number of Flat:2

PE:- -

High:1,256.93

Open:1,227.57

Low:1,227.57

Close:1,227.45

Loading ...

DoorDash, Williams-Sonoma, and TKO Stock to Join the S&P 500 -- Barrons.com

Egg prices have become a symbol of our economic fragility

Beam Therapeutics Shares up 10.4% Premarket After Early-Stage Data for Gene Editing Therapy

THOMSON REUTERS

Latest News In AI Chips - Leveraged ETFs Unlock Potent Trading Opportunities in Dynamic Markets

Simply Wall St.

Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results

3 Penny Stocks With Market Caps Exceeding $700M

Simply Wall St.

Whitestone REIT Commences Transformation of Merchandising Mix at Davenport Village in Austin, Texas

Press Release: BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

One of Wall Street's biggest bulls now says a flash crash can't be ruled out

Panama to Probe CK Hutchinson-Blackrock Deal for Panama Canal Ports

MT Newswires Live

BUZZ-Crypto shares fall, tracking weakness in bitcoin

BRIEF-Beam Therapeutics Announces Pricing Of Underwritten Offering

BRIEF-Beam Therapeutics BEAM-302 Was Well Tolerated At All Dose Levels

Beam Therapeutics: Single Dose of Beam-302 Led to Durable, Dose-Dependent Increases in Total and Functional Alpha-1 Antitrypsin

THOMSON REUTERS

Beam Therapeutics: Pricing of Underwritten Offering of 16.2 Mln Shares at Price $28.48 per Share

THOMSON REUTERS

CING: April Pre-NDA Meeting

Zacks Small Cap Research

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4535/news?page=28"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4535"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4535\",,,,,undefined,":{"symbol":"BK4535","market":"US","secType":"PLATE","nameCN":"Temasek Holdings","latestPrice":1254.4985,"timestamp":1741982399999,"preClose":1227.4463,"halted":0,"volume":625167604,"delay":0,"changeRate":0.022039,"change":27.052246,"pbRate":6.045503,"amount":53016817111.48299,"amplitude":0.023916,"prevYearClose":1309.0717,"fiveDayClose":1272.468,"twentyDayClose":1364.1459,"turnoverRate":0.010611,"marketCap":9027104482678.125,"floatMarketCap":8402927041875.75,"peRate":33.026424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4535\",,,,,undefined,":{"symbol":"BK4535","high":1256.9275,"amplitude":0.023916,"preClose":1227.4463,"low":1227.5719,"pbRate":"6.045503","latestPrice":1254.4985,"volume":625167604,"delay":0,"open":1227.5719,"prevYearClose":1309.0717,"prevWeekClose":1272.468,"prevMonthClose":1313.2322,"prevQuarterClose":1309.0717,"fiveDayClose":1272.468,"twentyDayClose":1364.1459,"sixtyDayClose":1366.4652,"secType":"PLATE","market":"US","turnoverRate":0.010611,"peRate":33.026424,"marketCap":9027104482678.125,"floatMarketCap":8402927041875.75,"timestamp":1741982399999,"nameCN":"Temasek Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4535\",,,,undefined,":{"bkCode":"BK4535","up":77,"down":7,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4535\",pageSize:16,pageCount:28,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518247904","title":"DoorDash, Williams-Sonoma, and TKO Stock to Join the S&P 500 -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2518247904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518247904?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:27","pubTimestamp":1741606020,"startTime":"0","endTime":"0","summary":"DoorDash, World Wrestling Entertainment owner TKO Group, home goods retailer Williams-Sonoma, and natural-gas producer Expand Energy will be added to the S&P 500, effective before the start of trading on March, as part of a quarterly reshuffling of the index.BorgWarner, Teleflex, Celanese, and FMC will be removed.DoorDash shares rose 7% in Friday after-hours trading to $190, while TKO stock was up 3% to $148, and Williams-Sonoma stock rose 2% to $192. Expand Energy stock edged up 1.5% to $98.Among the companies that will be removed, shares of BorgWarner, which designs and manufactures automotive systems, rose 2% to $30 in Friday after-hours trading, while shares of medical-device maker Teleflex and chemical company Celanese were mostly flat.However, the stocks sell off by an average of 1.3% in the first week following index inclusion, and are down around 1% in the following four weeks, the analysts wrote.In addition, stocks selected for addition have sold off on average by 16 base poin","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPRO","LU1804176565.USD","EXE","BK4122","LU0345770993.USD","SDS","BK4178","OEX","TKO","BK4550","BK4581","BK4536","BK4551","OEF","LU0345770308.USD","BK4535","BK4559","BK4588","SPY","LU0345769631.USD","BK4503","BK4549","ESmain","SPXU","WSM","LU0345769128.USD","SSO","BK4213","BK4504","DASH","BK4505","BK4534","VOO","SH","BK4585","IVV","LU2265009873.SGD","BK4108","BK4209",".SPX","BK4548"],"gpt_icon":0},{"id":"2518421262","title":"Egg prices have become a symbol of our economic fragility","url":"https://stock-news.laohu8.com/highlight/detail?id=2518421262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518421262?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:21","pubTimestamp":1741605660,"startTime":"0","endTime":"0","summary":"Why are eggs so important in our battle against inflation?The Justice Department has launched an investigation into the reasons for the surge in egg prices, the Wall Street Journal reported Friday, citing people familiar with the issue. Antitrust enforcers will focus on whether producers have conspired to hike egg prices.The price of eggs has risen by 50% over the past year. The average cost of a dozen Grade A large eggs hovers at $4.95, up 240% from $1.46 five years ago. We grudgingly accept those kinds of price hikes with real estate, especially if we are homeowners. But eggs?Eggs are an \"inelastic\" commodity: as prices rise customers don't necessarily stop buying them; there are precious few alternatives. Economist Jason Lusk says a 1% rise in price only reduces demand by 0.15% and, if the supply falls by 1%, prices will rise by about 6.67%.The Trump administration last month announced a $1 billion plan to combat avian influenza, to protect the U.S. poultry industry and - in theory,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","BK4212","CALM","LU0471298777.SGD","LU0385154629.USD","LU0079474960.USD","VITL","IE0008368304.USD","BK4209","LU0471298694.HKD","LU1496350502.SGD","LU2125154778.USD","LU0302445910.USD","BK4533","LU2360032135.SGD","LU0312595415.SGD","LU1323610961.USD","LU0980610538.SGD","BK4588","LU0417517546.SGD","LU0882574139.USD","LU0820561909.HKD","BK4535","KR","LU1551013342.USD","LU0265550946.USD","BK4550","IE00BKVL7J92.USD","LU1035775433.USD","BK4532","BK4559","LU1116320737.USD","LU2360106947.USD","LU0265550359.USD","LU0256863811.USD","BK4504","LU1069344957.HKD","SBUX","LU1066051498.USD","LU1066053197.SGD","LU2210149790.SGD","LU0823411888.USD","LU1201861249.SGD","BK4610","LU2125154935.USD","LU0345770308.USD","LU0130102774.USD","BK4596","LU0234570918.USD"],"gpt_icon":1},{"id":"2518244706","title":"Beam Therapeutics Shares up 10.4% Premarket After Early-Stage Data for Gene Editing Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244706?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:10","pubTimestamp":1741605059,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0K2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4556","BK4535","BK4505","BK4585","BK4611","BK4139","BEAM","BK4588"],"gpt_icon":0},{"id":"2518240672","title":"Latest News In AI Chips - Leveraged ETFs Unlock Potent Trading Opportunities in Dynamic Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240672","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518240672?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604846,"startTime":"0","endTime":"0","summary":"GraniteShares has launched two new leveraged exchange-traded funds  focusing on AI chip technology, offering sophisticated investors amplified exposure to two prominent stocks: MARA Holdings and Marvell Technology. These ETFs, named GraniteShares 2x Long MARA Daily ETF  and GraniteShares 2x Long MRVL Daily ETF , aim to achieve 200% of the daily performance of MARA and MRVL, respectively, allowing for tactical trading based on market trends and news. The funds cater to investors interested in short-term momentum within the digital asset and semiconductor technology sectors. GraniteShares continues to expand its portfolio of leveraged single-stock ETFs, catering to traders seeking high-conviction opportunities in dynamic markets.Marvell Technology last closed at $70.84 down 2%.In other trading, Broadcom was trading firmly up 8.6% and closing at $194.96. At the same time, MediaTek lagged, down 4.8% to end trading at NT$1,395.00.For an in-depth exploration of the AI Chips investment landsc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/latest-news-ai-chips-leveraged-110726051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MVLL","BK4575","BK4579","LU0321505868.SGD","LU0321505439.SGD","BK4533","BK4554","LU0081259029.USD","FDN","BK4585","BK4512","BK4515","BK4529","BK4602","BK4612","NVDA","BK4535","AMD","BK4543","BK4534","INTC","BK4141","BK4527","MRAL","BK4605","BK4588","BK4550"],"gpt_icon":1},{"id":"2518423852","title":"Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518423852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518423852?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604820,"startTime":"0","endTime":"0","summary":"Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039587/0/en/Design-Therapeutics-Highlights-Progress-Across-Lead-GeneTAC-Programs-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","IE00B1XK9C88.USD","LU1035775433.USD","LU0868494617.USD","BK4566","PRGS","SG9999001440.SGD","IE00BZ1G4Q59.USD","LU0868494708.USD","LU0943347566.SGD","BK4505","BK4504","LU1093756168.USD","BK4539","BK4023","LU1674673691.USD","BK4585","PK","IE00BKVL7J92.USD","LU1989772840.SGD","HD","LU0820561818.USD","LU1093756325.SGD","LU1496350171.SGD","PD","BK4535","FA","BK4097","LU1914381329.SGD","LU0942090050.USD","LU1169590202.USD","LU1778281490.HKD","LU0079474960.USD","LU0823411888.USD","DSGN","LU1162221912.USD","BK4588","IE00BWXC8680.SGD","LU0320765646.SGD","LU0234572021.USD","LU0823434740.USD","LENZ","BK4218","BK4181","LU2756315318.SGD","LU0820562030.AUD","LU2756315664.SGD","LU1929549753.HKD","BK4534","BK4533"],"gpt_icon":0},{"id":"2518872240","title":"3 Penny Stocks With Market Caps Exceeding $700M","url":"https://stock-news.laohu8.com/highlight/detail?id=2518872240","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518872240?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:04","pubTimestamp":1741604694,"startTime":"0","endTime":"0","summary":"The U.S. stock market recently experienced a mix of gains and declines, with major indices like the S&P 500 and Nasdaq facing their third consecutive weekly drop. In such fluctuating conditions, investors often seek opportunities in smaller or newer companies that might offer growth potential at lower price points. Penny stocks, despite the term's outdated feel, remain a relevant investment area; when these stocks are backed by solid financials and strong fundamentals, they can present hidden opportunities for significant returns.FIGS, Inc., a direct-to-consumer healthcare apparel company, has faced challenges typical of penny stocks. Despite a market cap of approximately US$781.72 million and no debt, FIGS's financial performance has been under pressure with declining net income from US$22.64 million in 2023 to US$2.72 million in 2024, alongside shrinking profit margins. The company's earnings are forecasted to grow significantly at 43.89% per year but remain volatile with recent insi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/3-penny-stocks-market-caps-110454429.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-penny-stocks-market-caps-110454429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["TTI","BK4532","EVS.SI","BK4563","BK4526","BK4585","BK4209","BK4179","BK4505","BK4548","BK4509","09866","BK4574","BK4581","BK4198","BK6125","BK4535","LU1878469433.USD","VTEX","BK4549","BK4531","BABB","BK4213","BK4561","BK4021","BK4202","NIO","LU0052750758.USD","FIGS","BK4555","BK4077","SB","LU0320764599.SGD","BK4099","BK4539","BK4504","LU0708995583.HKD","PHX","NIO.SI","BK4534","BK4588"],"gpt_icon":1},{"id":"2518244524","title":"Whitestone REIT Commences Transformation of Merchandising Mix at Davenport Village in Austin, Texas","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244524","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244524?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:00","pubTimestamp":1741604400,"startTime":"0","endTime":"0","summary":"Positioning asset to become an 18-hour activity hub that better serves the lifestyle needs of the surrounding community. Meets neighborhood demand for an upscale coffeehouse, premium fitness concepts and executive suites by bringing in Starbucks Reserve, Pvolve, RVE Fitness and CUBExec. HOUSTON, March 10, 2025  -- Whitestone REIT , a neighborhood-focused owner and operator of open-air shopping centers in Texas and Arizona, today announced that it has commenced a strategic transformation of the merchandising mix at Davenport Village  in Austin, Texas that is expected to re-energize the center and strengthen its competitive position within the upscale neighborhoods it serves: Davenport Ranch, Westlake, Rob Roy and Barton Creek. Whitestone is creating a vibrant, 18-hour activity hub that more appropriately serves the lifestyle needs of the area and offers greater optionality for West Austin’s large number of seasoned entrepreneurs and business professionals. To support its vision for Dave","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/whitestone-reit-commences-transformation-merchandising-110000602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","LU0882574139.USD","BK4585","BK4535","WSR","IE00B3T34201.USD","BK4504","BK4080","REIT","BK4610","LU0823411888.USD","SBUX","BK4209","BK4588"],"gpt_icon":0},{"id":"2518241637","title":"Press Release: BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2518241637","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518241637?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:55","pubTimestamp":1741604100,"startTime":"0","endTime":"0","summary":"-- Advanced oncology pipeline including more than 20 active Phase 2 and. Phase 3 clinical trials with a strategic focus on two priority pan-tumor. -- Multiple data readouts expected in 2025 and 2026 aimed at providing. clinical proof of BioNTech's pipeline strategy and advancing the Company. towards becoming a diversified multi-product oncology portfolio company. -- Completed acquisition of Biotheus securing full control of. -- Successfully launched JN.1- and KP.2-adapted COVID-19 vaccines across. different countries and regions and maintained global market leadership. -- Fourth quarter and full year 2024 revenues of EUR1.2 billion and. -- Full year 2024 net loss of EUR0.7 billion and diluted loss per share of. -- Cash and cash equivalents plus security investments of EUR17.4 billion as. Conference call and webcast scheduled for March 10, 2025, at 8:00 a.m. EDT . MAINZ, Germany, March 10, 2025  -- BioNTech SE  today reported financial results for the three months and full year ended De","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0868494617.USD","SG9999013999.USD","BK4585","SG9999011175.SGD","BK4533","LU0985481810.HKD","LU1066053197.SGD","SG9999001176.USD","BK4599","LU0058720904.USD","BK4550","BNTX","IE00BLSP4452.SGD","LU0225771236.USD","LU0456855351.SGD","LU1057294990.SGD","BK4534","BK4007","SG9999002232.USD","LU0225284248.USD","LU1883839398.USD","SG9999003800.SGD","SG9999002224.SGD","IE0002270589.USD","IE00BBT3K403.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","BK4568","LU0306806265.USD","LU0321505868.SGD","LU0170899867.USD","BK4581","LU1894683264.USD","IE00B19Z3B42.SGD","LU0234572021.USD","IE000M9KFDE8.USD","BK4548","BK4139","LU1023059063.AUD","LU0122379950.USD","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","SGXZ57979304.SGD","BK4535","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2518241310","title":"One of Wall Street's biggest bulls now says a flash crash can't be ruled out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518241310","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518241310?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:52","pubTimestamp":1741603920,"startTime":"0","endTime":"0","summary":"The stock market looks ready to resume selling again after last week's rout. President Donald Trump has said \"a little time\" may be needed for his tariff plan to start returning wealth to Americans, but Wall Street patience is running razor thin.\"Strong postelection vibes were an important part of the bullish consensus on 2025 for U.S. equities which hasn't panned out,\" observed RBC Capital Markets' head of  U.S. equity strategy research, Lori Calvasina.Our call of the day flips to one of Wall Street's biggest bears, Yardeni Research president Ed Yardeni, who is getting nervous. His forecast for a 7,000 finish for the index, which he shares with Deutsche Bank, is second only to 7,100 at Oppenheimer.Yardeni said the market and economy is getting stress-tested by Trump turmoil, and he just raised chances of a recession and bear market for stocks to 35%, from 20% over the past three years.So without a Trump put either, stock market bulls need to \"bet on the resilience of the economy and e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US7Y.BOND","LU0082616367.USD","IE00BQXX3D17.EUR","US6M.BOND","SG9999000418.SGD","LU1934455194.USD","LU0353189680.USD","LU1917777945.USD","LU2360106780.USD","LU2237443622.USD","LU0198837287.USD","LU0068578508.USD","BK4585","BK4535","LU0264606111.USD","US12M.BOND","BK4550","IE00BQXX3F31.USD","LU0348723411.USD","US5Y.BOND","US30Y.BOND","LU0070302665.USD","03145","LU2108987350.USD","US10Y.BOND","LU2750360641.GBP","BK4512","US2Y.BOND","BK4551","BK4549","LU0081259029.USD","LU0823414551.USD","DASH","IE0004091025.USD","LU0433182093.SGD","LU1803068979.SGD","LU1035773651.USD","LU1366333091.USD","BK4591","LU1201861249.SGD","SGXZ99366536.SGD","LU2357125470.USD","LU0689626769.HKD","LU0143863198.USD","US3Y.BOND","BK4548","BK4532"],"gpt_icon":1},{"id":"2518249630","title":"Panama to Probe CK Hutchinson-Blackrock Deal for Panama Canal Ports","url":"https://stock-news.laohu8.com/highlight/detail?id=2518249630","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518249630?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:35","pubTimestamp":1741602952,"startTime":"0","endTime":"0","summary":"The Panama Maritime Authority will seek legal and financial papers regarding a transaction between CK Hutchison  and a Blackrock-led consortium for the purchase of a stake in two ports near the Panama Canal, minister to presidency Juan Carlos Orillac said in a Friday news release.Panamanian authorities are seen to assess the transaction to ensure protection of public interest, Orillac said.Blackrock earlier annoucned that its consortium, which includes Global Infrastructure Partners and Terminal Investment, will buy the port business of CK Hutchison, including its 90% stake in Panama Ports Company, according to a separate Reuters report.Panama Ports operaes the Balboa and Cristobal ports near the Panama Canal under a 25-year concession, the report said.The deal between CK Hutchinson and BlackRock will involve the Hong Kong firm's 80% stake in Hutchinson Ports with an equity value of $14.21 bilion, but the conglomerate is seen to receive $19 billion following the repayment of shareholde","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0772969993.USD","LU0070302665.USD","IE0032431581.USD","BK4581","LU0980610538.SGD","LU2430703095.HKD","BK4588","IE00BVYPNW00.USD","LU1280957306.USD","LU0731783048.USD","LU1599440770.SGD","IE00BGHQF631.EUR","BK4533","BK1569","BK1521","LU1509826696.USD","LU0072462343.USD","LU0648001328.SGD","BK1230","BLK","LU2592432038.USD","00001","IE00BGHQF748.EUR","IE00BVYPNV92.GBP","IE00B42XCP33.USD","LU1670627923.USD","BK4504","LU1670628061.USD","LU0731783394.SGD","LU1989771016.USD","BK4534","LU2264538146.SGD","BK4567","IE00B3PB1722.GBP","IE00BDGV0183.EUR","LU1291159041.SGD","BK1500","LU1064131342.USD","LU1201861249.SGD","LU1481011671.HKD","LU0640476718.USD","BK4585","LU1571399168.USD","LU1988902786.USD","LU1048588211.SGD","BK4135","LU0208291251.USD","LU0130102774.USD","BK1601","BK4535"],"gpt_icon":0},{"id":"2518245057","title":"BUZZ-Crypto shares fall, tracking weakness in bitcoin","url":"https://stock-news.laohu8.com/highlight/detail?id=2518245057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518245057?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:24","pubTimestamp":1741602269,"startTime":"0","endTime":"0","summary":"BUZZ-Crypto shares fall, tracking weakness in bitcoin** Shares of cryptocurrency and blockchain-related companies down in premarket trading, as bitcoin falls** Bitcoin BTC=, the world's biggest crypto","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4539","BK4596","BK4112","BK4551","RIOT","MARA","BK4547","COIN","CLSK","STRK","BK4585","BK4608","MSTR","BITF","BK4595","LU1861559042.SGD","BK4554","HUT","BK4023","LU1861558580.USD","BK4516","BK4600","BK4588"],"gpt_icon":1},{"id":"2518245974","title":"BRIEF-Beam Therapeutics Announces Pricing Of Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2518245974","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518245974?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:18","pubTimestamp":1741601904,"startTime":"0","endTime":"0","summary":"BRIEF-Beam Therapeutics Announces Pricing Of Underwritten OfferingMarch 10 (Reuters) - Beam Therapeutics Inc BEAM.O:BEAM THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN OFFERINGBEAM THERAPEUTICS: PRICI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PS055:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4611","BK4535","BK4585","BK4588","BK4139","BK4505","BEAM"],"gpt_icon":0},{"id":"2518245835","title":"BRIEF-Beam Therapeutics BEAM-302 Was Well Tolerated At All Dose Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2518245835","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518245835?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:11","pubTimestamp":1741601495,"startTime":"0","endTime":"0","summary":"BRIEF-Beam Therapeutics BEAM-302 Was Well Tolerated At All Dose LevelsMarch 10 (Reuters) - Beam Therapeutics Inc BEAM.O:BEAM THERAPEUTICS: BEAM-302 WAS WELL TOLERATED AT ALL DOSE LEVELSBEAM THERAPEUTI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PS057:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BEAM","BK4505","BK4556","BK4535","BK4139","BK4611"],"gpt_icon":0},{"id":"2518458872","title":"Beam Therapeutics: Single Dose of Beam-302 Led to Durable, Dose-Dependent Increases in Total and Functional Alpha-1 Antitrypsin","url":"https://stock-news.laohu8.com/highlight/detail?id=2518458872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518458872?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:09","pubTimestamp":1741601375,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PS057:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","BK4139","BK4585","BK4588","BEAM","BK4505","BK4535","BK4556"],"gpt_icon":0},{"id":"2518025248","title":"Beam Therapeutics: Pricing of Underwritten Offering of 16.2 Mln Shares at Price $28.48 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2518025248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518025248?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:02","pubTimestamp":1741600920,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PS055:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BEAM","BK4505","BK4556","BK4139","BK4585","BK4611","BK4588"],"gpt_icon":0},{"id":"2518922748","title":"CING: April Pre-NDA Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2518922748","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518922748?lang=en_us&edition=fundamental","pubTime":"2025-03-10 17:40","pubTimestamp":1741599600,"startTime":"0","endTime":"0","summary":"Since the report of third quarter results, Cingulate, Inc.  has executed a $5 million capital raise, completed its fast-fed study and reported safety results from its Phase III trials. As we move down the home stretch towards the FDA submission, Cingulate has a pre-new drug application  meeting scheduled for early April and anticipates filing its NDA with the agency by mid-2025. We also expect to see further safety data from the consolidated Phase III studies at an upcoming but as yet unidentified scientific conference.The pathway forward for FDA submission includes several parallel efforts which include updating stability data on 2024 batches of CTx-1301, completing the analysis of the fast fed study and attendance at the pre-NDA meeting with the FDA in early April. Notes from the meeting are expected about a month later, which will provide final details required for completing the NDA. NDA submission is expected by mid-2025. We anticipate a 10-to-12-month turnaround time by the agenc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cing-april-pre-nda-meeting-094000188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4007","BK4551","BK4023","BK4218","PK","CING","CMAX","BK4503","BK4535","BK4181","CINGW","API"],"gpt_icon":0}],"pageSize":16,"totalPage":74,"pageCount":28,"totalSize":1178}]}}